Bojangles’, Inc. Reports Financial Results for its First Fiscal Quarter 2018
May 08, 2018 20:05 pm UTC| Business
CHARLOTTE, N.C., May 08, 2018 -- Bojangles’, Inc. (Bojangles’) (NASDAQ:BOJA) today announced financial results for the 13-week first fiscal quarter ended April 1, 2018. Bojangles’ also reiterated its annual guidance for...
Extraction Oil & Gas, Inc. Announces First-Quarter 2018 Results
May 08, 2018 20:04 pm UTC| Business
DENVER, May 08, 2018 -- Extraction Oil Gas, Inc. (NASDAQ:XOG) (“Extraction” or the “Company”) today reported financial and operational results for the first quarter of 2018. First-Quarter 2018 Highlights First...
OSS Reports First Quarter 2018 Results: Revenue up 12% to $7.1 Million; Reiterates 2018 Guidance
May 08, 2018 20:04 pm UTC| Business
ESCONDIDO, Calif., May 08, 2018 -- OSS (NASDAQ:OSS), a leading provider of high performance computing systems, reported results for the quarter ended March 31, 2018 and reiterates its guidance for 2018. Financial...
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 08, 2018 20:03 pm UTC| Business
MENLO PARK, Calif., May 08, 2018 -- Dermira, Inc. (NASDAQ:DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of...
May 08, 2018 20:02 pm UTC| Business
PHOENIX, May 08, 2018 -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, announced today that it has agreed to...
FactSet Announces Planned Departure of its Chief Financial Officer
May 08, 2018 20:02 pm UTC| Business
NORWALK, Conn., May 08, 2018 -- FactSet (NYSE:FDS) (NASDAQ:FDS), a global provider of integrated financial information, analytical applications, and industry-leading services, today announced that it has entered into a...
Xenon Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update
May 08, 2018 20:02 pm UTC| Business
Xenon’s novel clinical stage epilepsy candidates, XEN1101 and XEN901, to be presented at upcoming 14th Eilat Conference on New Antiepileptic Drugs and Devices on May 15, 2018 BURNABY, British Columbia, May 08, 2018 --...